机器人对比开放I-II级下腔静脉癌栓取出术的配对分组比较分析
该回顾性配对研究比较了机器人对比开放下腔静脉癌栓取出术治疗肾肿瘤伴I-II级下腔静脉癌栓的疗效,机器人组围手术期指标更优,但肿瘤学结局无显著差异。作者结论认为机器人下腔静脉癌栓取出术可获得更有利的围手术期结果和相似的肿瘤学结局,但需更大样本、更长随访的前瞻性研究验证。
要点
- 机器人组中位手术时间150 vs 230分钟,p<0.001,机器人组更短。
- 机器人组中位估计失血量250 vs 1,000 ml,p<0.001,机器人组更低。
- 两组肿瘤学结局无显著差异,但需更大样本前瞻性研究验证。
核心结论
- 机器人下腔静脉癌栓取出术可获得更有利的围手术期结果和与开放手术相似的肿瘤学结局。
- 作者指出需更大样本量和更长随访的前瞻性研究来验证该发现。
研究设计与样本
- 回顾性分析了2006年至2016年间接受机器人或开放下腔静脉癌栓取出术患者的病历资料。
- 为减少非随机研究的固有偏倚,机器人组和开放组按关键变量进行1:1配对。
- 共31例患者接受机器人下腔静脉癌栓取出术,37例接受开放下腔静脉癌栓取出术。
- 配对后两组基线特征无显著差异。
主要发现
- 配对队列中,机器人组中位手术时间显著短于开放组(150 vs 230分钟,p<0.001)。
- 机器人组中位估计失血量显著低于开放组(250 vs 1,000 ml,p<0.001)。
- 机器人组输血率显著低于开放组(6.5% vs 54.8%,p<0.001)。
- 机器人组中位输血需求量显著低于开放组(420 vs 790 ml,p=0.012)。
- 机器人组中位术后住院时间显著短于开放组(5 vs 9天,p<0.001)。
关键数值与推荐
- 术后并发症发生率机器人组低于开放组(9.7% vs 29.0%,p=0.070)。
- 两组肿瘤学结局无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究为回顾性研究。
- 本研究为非随机研究,存在固有偏倚,虽经1:1配对减少但未能完全消除。
- 作者指出需更大样本量和更长随访的前瞻性研究来验证该发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compared treatment outcomes of robotic vs open inferior vena cava thrombectomy for renal tumors with level I-II inferior vena cava tumor thrombus. MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients who underwent robotic or open inferior vena cava thrombectomy between 2006 and 2016. To reduce the inherent biases of a nonrandomized study the robotic and open groups were matched 1:1 based on key variables. Perioperative data and oncologic outcomes were reviewed. Progression-free and overall survival was analyzed using Kaplan-Meier survival curves and compared between groups using the log rank test. RESULTS: A total of 31 and 37 patients underwent robotic and open inferior vena cava thrombectomy, respectively. After matching there were no significant differences in baseline characteristics between the groups. Of the matched cohorts the robotic cohort had significantly shorter median operative time (150 vs 230 minutes, p <0.001), lower median estimated blood loss (250 vs 1,000 ml, p <0.001), a lower rate of blood transfusion (6.5% vs 54.8%, p <0.001), a lower median transfusion requirement (420 vs 790 ml, p = 0.012) and a shorter median postoperative hospital stay (5 vs 9 days, p <0.001). The postoperative complication rate was lower in the robotic group than in the open group (9.7% vs 29.0%, p = 0.070). However, there were no significant differences in oncologic outcomes between the groups. CONCLUSIONS: Robotic inferior vena cava thrombectomy can achieve more favorable perioperative results and similar oncologic outcomes compared with open inferior vena cava thrombectomy. Prospective studies with a larger sample size and longer followup are needed to validate our findings.
引用
- Gu L, Ma X, Gao Y, et al. Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis. J Urol. 2017. PMID: 28694078. doi:10.1016/j.juro.2017.06.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。